Marrow
Genomics · Genetic Reports · Precision Wellness

Nerve Health

Personalized Genetic Report
Central Nerve HealthPeripheral Nerve HealthFacial Nerve HealthNerve Health Genes
Sample ClientReport date: 29 July 2026
Genomics · Genetic Reports · Precision Wellness
Marrow Health Laboratories
Marrow
Accession #: MRW-26-EB54A3
Report type: Full Report
Report status: FINAL

Specimen and client information

Client
Sample Client
Specimen type
Buccal (cheek) swab
Date reported
29 July 2026
Accession
MRW-26-EB54A3
Panel
Nerve Health
Results scored
30 of 36
Need attention
5
Report
Full Report

What this report covers

Central Nerve Health · Peripheral Nerve Health · Facial Nerve Health · Nerve Health Genes

About this report

This report reads your DNA and sorts every result into one of five plain-language groups, so you can see at a glance what deserves attention and what does not. Nothing here is a diagnosis. A flagged result means your genetics place you above or below the average person for that trait — a reason to ask a question, not a reason to worry.

What each result group means

Worth a conversation with your doctor
These came back with a higher genetic predisposition than most people. That is not a diagnosis — it means these are the ones worth raising at your next appointment.
Running above the typical range
Your genetics point to these sitting higher than average. Often useful to know, sometimes worth monitoring.
Running below the typical range
Your genetics point to these sitting lower than average. Same idea — context, not alarm.
Working in your favour
Good news. Your genetics look protective or better than average here.
In line with most people
Nothing unusual. These were tested and came back typical — worth having on record.

Your results at a glance

How to read this. A result being flagged does not mean you have a condition — it means your genetics put you above or below the average person for that trait. Of the 30 results here, 5 came back worth discussing with a clinician and 2 came back in your favour. Bring this document to your appointment.
Worth a conversation with your doctor  (5)These came back with a higher genetic predisposition than most people. That is not a diagnosis — it means these are the ones worth raising at your next appointment.
From your Nerve Health report
AFacial Pain
More likely
Higher predisposition than 98% of people
ADroopy Eyelids
More likely
Higher predisposition than 97% of people
SERP1 rs1520818 TT · ARSB rs4704521 CC · ATP8A1 rs6447160 TT · DLGAP1 rs11876749 TT · ATP8A1 rs16854624 CC · DLGAP1 rs7239297 GG · FZD4 rs674017 AC · COX10 rs12451218 TT
ATremor
More likely
Higher predisposition than 82% of people
CNTNAP5 rs142107007 CC · HDAC4 rs74641417 GG · FBLN5 rs2249946 TT · CRK rs58143069 GG · VEPH1 rs703174 CC · DPP6 rs2035847 GG · ZNF385D rs9867308 GG · PRCP rs949247 CC
AParkinson's Disease
More likely
Higher predisposition than 70% of people
MAPT rs17649553 CC · LINGO2 rs10812774 TC · STK39 rs1474055 TT · HLA-DQA2 rs9275326 CC · FYN rs943437 AA · TMEM229B rs1555399 TT · NDUFAF2 rs2694528 AC · NUCKS1 rs823118 TC
ADiabetic Neuropathy
More likely
Higher predisposition than average
TTC19 rs522521 CC
Running above the typical range  (2)Your genetics point to these sitting higher than average. Often useful to know, sometimes worth monitoring.
From your Nerve Health report
HTRPM8 (Pain)
Higher activity
Above the typical range
HKIBRA/WWC1 (Cognition)
Higher activity
Above the typical range
WWC1 rs17070145 TT
Running below the typical range  (2)Your genetics point to these sitting lower than average. Same idea — context, not alarm.
From your Nerve Health report
LTRPV1 (Pain)
Lower activity
Lower than 85% of people
TRPV1 rs8065080 CT · SHPK rs222748 AG · TRPV1 rs222747 GC · SHPK rs222741 GA · TRPV1 rs79821076 GG · ASPA rs7217270 GG · TRPV1 rs56095209 CC · TRPV3 rs4790522 CC
LENPP6 (Cognition)
Lower activity
Below the typical range
ENPP6 rs4241784 GG
Working in your favour  (2)Good news. Your genetics look protective or better than average here.
From your Nerve Health report
FSpeech Disorder
Less likely
Lower predisposition than 86% of people
FCognitive Decline
Less likely
Lower predisposition than 99% of people
CDCA7 rs182734936 CC · ANXA5 rs141005242 CC · TEK rs147486058 AA · DUSP15 rs6089150 CC · CTBP2 rs61869228 CC · HHEX rs60320343 AA · CRP rs1205 CC · FOXO3 rs4946936 CC
In line with most people  (19)Nothing unusual. These were tested and came back typical — worth having on record.
From your Nerve Health report
·Trigeminal Nerve Pain
Typical likelihood
In line with the general population · 68th percentile
KIF26B rs529486807 GG · NKX6-1 rs192701796 GG · DCHS2 rs150202160 AA · CDKN2C rs140830175 CC · PTCHD4 rs566133650 TT · GPX6 rs547001128 GG · TENT2 rs182465936 CC · FANCL rs10190169 CC
·Alzheimer's Disease
Typical likelihood
In line with the general population · 65th percentile
CD55 rs3818361 GA · POLR2E rs12151021 AA · HLA-DRB1 rs9271192 AC · SORT1 rs11102972 TC · CLNK rs6846529 CT · COX7C rs62374257 CT · CPSF3 rs72777026 AG · IGHG3 rs7157106 GA
·Stroke
Typical likelihood
In line with the general population · 63th percentile
PITX2 rs6843082 AG · SPSB4 rs16851055 AG · HTRA1 rs60401382 CC · SWAP70 rs10840293 AA · DACH1 rs339800 TC · JCAD rs2487928 GA · COL4A1 rs9521634 TC
·Burning Mouth Syndrome
Typical likelihood
In line with the general population · 62th percentile
DRD2 rs6277 GG · IL1B rs16944 AG · IL1B rs1143634 GG
·Multiple Sclerosis
Typical likelihood
In line with the general population · 60th percentile
EBPL rs9591325 TT · IL2RA rs2104286 TT · RBM17 rs11256593 TT · TYK2 rs34536443 GG · TAPBPL rs12832171 CC · JAK1 rs72922276 GG · RGS1 rs1323292 AA · RTEL1-TNFRSF6B rs6742 CC
·Carpal Tunnel Syndrome
Typical likelihood
In line with the general population · 56th percentile
UMPS rs4678145 GG · LNPK rs847139 CC · EFEMP1 rs3791679 AG · ADAMTS14 rs747141 GA · TBX18 rs62422907 AG · TNP1 rs1863190 TA · AEBP1 rs55841377 CG · AOC1 rs6977081 TG
·Difficulty Swallowing
Typical likelihood
In line with the general population · 43th percentile
FGFR2 rs17601696 CC · COL9A1 rs701682 CC
·Tics
Typical likelihood
In line with the general population · 33th percentile
OTUD1 rs191044310 TT · CSMD3 rs117648881 GG · FAM76B rs11021169 GG · XYLT1 rs74772983 AA · CLN5 rs11149058 TT · TSPYL5 rs117780640 CC · CCDC66 rs6445765 CC · SGPP2 rs1865896 GG
·Paresthesia
Typical likelihood
In line with the general population · 23th percentile
·Nerve Compression
Typical likelihood
In line with the general population · 22th percentile
UMPS rs4678145 GG · LNPK rs847139 CC · EFEMP1 rs3791679 AG · COL11A1 rs12406439 TT · ADAMTS14 rs747141 GA · TBX18 rs62422907 AG · TNP1 rs1863190 TA · AEBP1 rs55841377 CG
·Brain Cancer
Typical likelihood
In line with the general population
STMN3 rs6010620 GG · TERT rs10069690 CT · RAVER2 rs12752552 TT · LRIG1 rs11706832 CC · TREH rs498872 GA · ACTRT3 rs3772190 GG · ZBTB16 rs648044 AG · TP53 rs78378222 TT
·Brain Ischemia
Typical likelihood
In line with the general population
TWIST1 rs2107595 AG · HP rs879324 AA · PITX2 rs6843082 AG · ALDH2 rs2238151 TT · ABCG5 rs76866386 TT · ABO rs532436 AA · PTPRF rs6695915 AA · LIPA rs1412444 TT
·Dystonia
Typical likelihood
In line with the general population
·Seizures
Typical likelihood
In line with the general population
CDK5RAP3 rs4794333 TT · KRTAP8-1 rs2833098 AA · PCDH7 rs1044352 GT · GABRA2 rs11943905 TC · FMN2 rs12059546 GA · TTC21B rs11890028 TT · GOLIM4 rs111577701 CC · TTC21B rs6732655 TT
·Neuropathic Pain
Typical likelihood
In line with the general population
ACTRT2 rs115353340 CC · SLC17A3 rs79154996 GG · SEC61A2 rs12775058 CC · EXOSC6 rs150309683 TT · RAB28 rs138847726 CC · TYRP1 rs71507307 GG · PPDPFL rs77526294 GG · FES rs4331318 CC
·Peripheral Neuropathy
Typical likelihood
In line with the general population
·Bell's Palsy
Typical likelihood
In line with the general population
ROBO2 rs6789770 GG · NFKBIE rs9357446 GA · INO80B rs75192983 TC · TENT5A rs7744539 GG · CD55 rs746932610 GG · POU3F1 rs77633398 GG · MGA rs139213873 CC · SLC2A1 rs80136426 CC
·IDO (Kynurenine)
Typical levels
In line with the general population
NLRP12 rs4632248 GG
·SCN9A (Pain)
Typical activity
In line with the general population
SCN9A rs6746030 GG

Methodology

Genotyping was performed on DNA extracted from a buccal (cheek) swab using a genome-wide array. Results are derived from peer-reviewed genome-wide association data and, where applicable, published clinical guidelines. Each report was scored independently against its own reference set. Percentile figures describe where your result sits relative to a reference population.

Limitations

This is a laboratory-developed test. It has not been cleared or approved by the U.S. Food and Drug Administration. Genotyping does not detect all variants in the genes assessed; the absence of a flagged result does not exclude risk. Predisposition is probabilistic and is modified by environment, lifestyle, ancestry and family history. Results must be interpreted by a qualified healthcare professional and must not be used alone to diagnose, treat, or alter any medication regimen. Marrow does not recommend, prescribe, or dose any supplement or medication.

Performing laboratory & attestation
Performing laboratoryGene by Gene, Ltd.
Laboratory address1445 North Loop West, Suite 760, Houston, TX 77008
CLIA certificationCLIA #45D1102202
CAP accreditationCAP #7212851 · accredited through 7 October 2027
Laboratory DirectorFeng Zhou, PhD, MB(ASCP)
Specimen typeBuccal (cheek) swab — genomic DNA
AccessionMRW-26-EB54A3
Date reported29 July 2026

This specimen was tested at Gene by Gene, Ltd., 1445 North Loop West, Suite 760, Houston, TX 77008, under CLIA #45D1102202 and CAP #7212851. Laboratory Director: Feng Zhou, PhD, MB(ASCP). Marrow Health is not a clinical laboratory and does not perform testing; Marrow prepares and delivers this report from data produced by the performing laboratory named above. Report generated 29 July 2026 · Accession MRW-26-EB54A3 · © 2026 Marrow Health.